BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9743328)

  • 1. Superclustering of B cell receptor and Fc gamma RIIB1 activates Src homology 2-containing protein tyrosine phosphatase-1.
    Sato K; Ochi A
    J Immunol; 1998 Sep; 161(6):2716-22. PubMed ID: 9743328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.
    Nakamura K; Cambier JC
    J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions.
    Nakamura K; Brauweiler A; Cambier JC
    J Immunol; 2000 Jan; 164(2):631-8. PubMed ID: 10623804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
    Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
    Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
    J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling.
    Henshall TL; Jones KL; Wilkinson R; Jackson DE
    J Immunol; 2001 Mar; 166(5):3098-106. PubMed ID: 11207261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
    Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
    J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation.
    Malbec O; Fong DC; Turner M; Tybulewicz VL; Cambier JC; Fridman WH; Daëron M
    J Immunol; 1998 Feb; 160(4):1647-58. PubMed ID: 9469421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of B cell signal transduction by SH2-containing protein-tyrosine phosphatases.
    Siminovitch KA; Neel BG
    Semin Immunol; 1998 Aug; 10(4):329-47. PubMed ID: 9695189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperation between SHP-2, phosphatidyl inositol 3-kinase and phosphoinositol 5-phosphatase in the Fc gamma RIIb mediated B cell regulation.
    Sármay G; Koncz G; Pecht I; Gergely J
    Immunol Lett; 1999 May; 68(1):25-34. PubMed ID: 10397152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1.
    D'Ambrosio D; Hippen KL; Minskoff SA; Mellman I; Pani G; Siminovitch KA; Cambier JC
    Science; 1995 Apr; 268(5208):293-7. PubMed ID: 7716523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation.
    Adachi T; Flaswinkel H; Yakura H; Reth M; Tsubata T
    J Immunol; 1998 May; 160(10):4662-5. PubMed ID: 9590210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Shp-2 tyrosine phosphatase activates the Src tyrosine kinase by a non-enzymatic mechanism.
    Walter AO; Peng ZY; Cartwright CA
    Oncogene; 1999 Mar; 18(11):1911-20. PubMed ID: 10208413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fc gamma receptor type IIb induced recruitment of inositol and protein phosphatases to the signal transductory complex of human B-cell.
    Sarmay G; Koncz G; Pecht I; Gergely J
    Immunol Lett; 1997 Jun; 57(1-3):159-64. PubMed ID: 9232445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
    Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
    Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
    Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
    J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative signaling pathways of the killer cell inhibitory receptor and Fc gamma RIIb1 require distinct phosphatases.
    Gupta N; Scharenberg AM; Burshtyn DN; Wagtmann N; Lioubin MN; Rohrschneider LR; Kinet JP; Long EO
    J Exp Med; 1997 Aug; 186(3):473-8. PubMed ID: 9236201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD2 and CD3 associate independently with CD5 and differentially regulate signaling through CD5 in Jurkat T cells.
    Carmo AM; Castro MA; Arosa FA
    J Immunol; 1999 Oct; 163(8):4238-45. PubMed ID: 10510361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The major SHP-1-binding, tyrosine-phosphorylated protein in macrophages is a member of the KIR/LIR family and an SHP-1 substrate.
    Berg KL; Carlberg K; Rohrschneider LR; Siminovitch KA; Stanley ER
    Oncogene; 1998 Nov; 17(19):2535-41. PubMed ID: 9824165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.